GlassScriptPhysician profile
James C Dowdy
NPI 1598767956
$4,609.29
in general payments reported to CMS, 2019-2025
25 companies · $563 in 2025
The $563 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $117 · 2021: $1,505 · 2022: $759 · 2023: $658 · 2024: $519 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,740.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,570.84 | 2021-2025 | Penumbra System, Indigo System |
| Medtronic, INC. | $954.99 | 2022-2025 | Endurant Iis, Everflex, Chocolate Pta Balloon Catheter |
| W. L. Gore & Associates, INC. | $576.86 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Inari Medical, INC. | $221.14 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Allergan, INC. | $212.59 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $201.57 | 2020-2022 | |
| Endologix LLC | $187.67 | 2019 | |
| Abbvie INC. | $171.25 | 2021-2024 | Dalvance |
| Merck Sharp & Dohme LLC | $58.99 | 2019-2022 | |
| Genentech USA, INC. | $55.81 | 2019-2023 | Erivedge |
| Innocoll Pharmaceuticals Limited | $50.18 | 2022 | |
| Pfizer INC. | $46.07 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $38.33 | 2022-2023 | Nuzyra |
| Intuitive Surgical, INC. | $36.10 | 2023 | Da Vinci Surgical System |
| Tetraphase Pharmaceuticals, INC. | $32.42 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bone Support INC. | $27.36 | 2024 | Cerament G, Ceramentbone Void Filler |
| Smith+Nephew, INC. | $26.61 | 2021 | |
| Ekos Corporation | $23.66 | 2019 | |
| Hologic INC | $21.29 | 2022 | |
| Angiodynamics, INC. | $19.99 | 2022 | |
| Kci USA, INC. | $17.06 | 2022 | |
| Tela Bio, INC. | $15.96 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.51 | 2020 | |
| Boston Scientific Corporation | $14.65 | 2022 | |
| Medtronic Vascular, INC. | $12.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Dowdy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.